Genprex Secures $6.5 Million in Funding to Advance Cancer and Diabetes Therapies
Genprex Secures $6.5 Million in Funding Through Registered Direct Offering Genprex, a leading gene therapy company, recently announced the closing of a $6.5 million registered direct offering priced at-the-market under...
Mar 22, 2024
• Major Pharmaceutical Preparations Industry
Stock Offering
NASDAQ
